disease was observed exclusively in males and, in each instance, transmis 'on was through a female.
In a trait transmitted as an X-linked recessive, one-fourth of the son an all e r s of carrier -females are expected to be affected. In this test of the hypothesis, the observed proportion of affected and unaffected grandsons did not differ significantly from this expectation.
The results of testing with Xga antiserum indicated that throughout most of the kindred the X chromosome carrying the pathologic hyperuricemic gene also carried the silent Xg gene. Recombination must be invoked to explain case 111-15, who was Xg (a+) and had an X g (a+) son and an involved son.
Neither the concentration of uric acid in the plasma nor the excretion of uric acid in the urine were useful in the detection of the abnormal gene. However, these data suggest that there may be soAe abnormality in uric acid metabolism in the heterozygote, but that it is not regularly possible to detect the presence of the abnormal gene by measuring the excretion of uric acid in the urine. The adult males were all found to excrete less uric acid than any of the groups of females.
The observations recorded provide further confirmation for the concept that the disorder under study is a distinct disease entity. Genetic data accumulating indicate that the disorder is inherited in an X-linked recessive pattern.
This condition has now been observed to present all the clinical manifestations of gout, including hyperuricemia, urinary tract crystals a n d calculi, renal failure, arthritis a n d tophi. I t differs in the age of onset a n d the involvement of the central nervous system. Most gout in adults appears t o b e renal in origin; some reflects a n overproduction of uric acid. T h e overproduction of uric acid in this condition greatly exceeds that of a n y form of gout in adults. It appears likely that the mechanism of overproduction will b e found likewise to be different. In the presence of X-linked transmission, i t should b e possible t o develop methods which detect the heterozygous carrier.
A syndrome of mental retardation, spastic cerebral palsy, choreoathetosis, and self-destructive biting has recently been described in children with elevated concentrations of uric acid in the blood [5] . Additional experience has confirmed the conclusion that this is a distinct disease entity [3, 4, 7, 8, 111 . Metabolic studies have indicated markedly increased turnover of uric acid and a striking overproduction of uric acid from glycine [5, 81. These observations indicate an abnormality in the biosynthesis of purines. I t is the purpose of this report to describe genetic studies which support an X-linked recessive mode of transmission. not marked at rest, but increased with intention in response to pleasurable or painful stimuli.
The diaper was crusted with orange crystalline material, which was assayed. There was a single uric acid spot on paper chromotography and quantitatively over 90 percent of the dry material was uric acid. The blood urea nitrogen was 14.5 and the plasma uric acid 9.9 mg per 100 ml.
Patient G.W. (kindred LW, IV-19) was studied at 5 years. He appeared listless at birth and developed slowly. By 15 months, he was able to pull himself around on the floor and had 3 to 4 words, but at 5 years he functioned less well. He had grand ma1 seizures.
Case Reports
Two new pedigrees have been constructed following the study of propositi ascertained by survey of the Sunland Hospital at Orlando.
Patient D. B. (kindred JHLBC, IV-33) was studied at 5 years of age. During infancy he had appeared well except that he cried quite a lot until 4 months, when he could not hold his head and was thought to be retarded. Spasticity was noted at 9 months. Generalized convulsions began at 3 years of age, subsiding after one year. He began to bite his left index finger and his lower lip shortly after the onset of seizures. At 3 years, he was getting about in a walker; at 5 years, he could not sit unassisted.
The patient was a well-proportioned, 14.1 kg white malewithathetoid cerebral palsy ( fig. 1 ). He wasseverely mentally retarded; in psychometric evaluation by Dr. FRANK LOEFFLER, he appeared to function at an 18-month level, which would represent a D Q of 30.
The lower lip was disfigured; a portion had been bitten off. There was a laceration of the left index finger. Biting behavior was observed to follow a regular pattern. He was generally calm and quiet, but on removal of restraints, he became extremely excited and scream-.--.. He appeared to be a well-proportioned 15.2 kg white male. He had moderate spasticity and a symmetrical increase in the deep tendon reflexes. Choreoathetosis was present, particularly on intention. Examination of the lower lip revealed shortening and loss of tissue which was observed in hospital to follow biting. There were scars on the hands and arms. Psychometric evaluation revealed profound deficit in intellectual function and a developmental age estimated at under one year.
The blood urea nitrogen was 13.5 and the plasma uric acid 1 1.7 mg per 100 ml.
Materials and Methods
The metabolic abnormality in patient D.B. was documented in the Clinical Research Unit of the University of Miami, in accordance with the protocol previously described [5] . A 'purine free' diet was used throughout. Methods employed for the isolation of uric acid, its assay, and its formation from glycine-U-CI4 have been described [5] . Pedigrees were constructed on the basis of data and pictures obtained from the families of the probands and from records of institutions for the retarded, and by direct observation. obtained from Pfizer Diagnostics through the courtesy of Dr. Amos Cahan. The erythrocytes of these family members were screened for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency using the method of O s~r and GROWNEY [9] and in about half of them, the screening test was confirmed using the quantitative method of GLOCK and MCLEAN [I] . Color vision was assessed using H-R-R Pseudoisochromaticplates under standard illumination from a New England Easel Lamp (American Optical Co.) and The Farnsworth Dichotomous Test. Twenty-four hour urine samples were obtained from family members during a 24-hour period in which purine intake was limited by the exclusion of meat and fish from the diet. Total volumes were recorded promptly on completion and aliquots of urine, as well as plasma samples were frozen until assayed. Erythrocytes obtained were washed twice with saline and separated into two aliquots. One was diluted 1 :1 with glycerol citrate solution and frozen for blood typing. The other was used for microhematocrit, the screening test for G-6-PD, and for a 1 : 20 hemolysate for quantitative assay of G-6-PD.
Results hfetabolic Investigation q f P a t i~n t D. B.
The concentration of uric acid in the serum was determined 5 times in a 7-month period. It varied from 7.4 to 9.9 mg per 100 ml. The concentration of uric acid in the cerebrospinal fluid was 0.3 mg per 100 ml. His excretion of uric acid in the urine ranged from 546 to 847 mg per 24 hours with a mean of 691 mg per 24 hours during a 6-day period of careful collections on a 'no purine' diet. Excretion of over 600 mg of uric acid per 24 hours in a gouty adult of approximately 70 kg is the criterion for classification as a hyperexcretor [2, 131. The mean excretion of 691 mg per day is 3 times that observed in control children of the same size as the patient [5] . Adjustment of the data for body weight yielded a range of 36.4 to 56.5 and a mean of 46.0 mg per kg per 24 hours, which is virtually identical to data obtained on other children with this disorder [5, 8] . Calculated in terms of creatinine excretion, his mean excretion of uric acid was 3.02 mg per mg of creatinine. Control children and control adults, even with gout, generally excrete less than 1.0 mg of uric acid per mg of creatinine.
The synthesis of uric acid was studied by determining the isotope content of urinary urate following the intravenous injection of 2 pc per kg of glycine-U-C14. The specific activity of the uric acid isolated was maximal at 118 cpm per mg in the first 12 hours after injection. The specific activities found differed clearly from those observed in controls [5] and there was no overlap throughout the period of study. At the peak, the specific activity in the patient approximated 4 times that of controls. In experiments of this type, it has not been possible to distinguish adults with gout from control adults [13] . Therefore, the cumulative recovery of the isotope of glycine in urinary uric acid has been employed to characterize those in whom gout is clearly associated wit5 overproduction of uric acid. Data obtained on D.B. are compared with those of controls in fig.2 . In the patient, 1.97 percent of the isotope administered was found in urinary uric acid in the 7 days of study. Some urine was lost during the collection of the second half of the third day, so that the true total should be somewhat higher. Control subjects converted only 0.01 percent of the isotope of glycine to uric acid in this period. The curve obtained for D. B. in fig. 2 looks like a duplicate of those found in 4 other patients studied [5, 7, 81 . The difference between patient and controls is of the order of magnitude of 200 times.
Cumulative % Injected Excreted as Uric Acid
Genetic studies. The first suggestion that this disorder might be transmitted in an X-linked pattern was con-2.00 -tained in the second report [8] . A pedigree ( fig. 3) Fig.3 . Pedigree of the family of R. S. constructed from acid in patient D. B. and in 3 control individuals follow-information contained in the report of the case [8] .
ing the administration of glycine-U-C14. structed from the data illustrates the transmission of the disorder to two sons of one mother by two fathers. The third son died at 4 months, which is too early to tell by historical data whether or not he had the disease. This observation was extended when information became available on the families of D. B. (fig.4) and G.W. (fig. 5 ). Among the relatives of D. B., there were 15 affected individuals. All were males. Clinical observations on these family members are summarized in table I. Among other members of the family, all appeared clearly to be uninvolved. The second son (IV-10) of 111-3 died at 9 months of pneumonia, but was developing normally prior to that acute disease, as was 111-14 who died of meningitis at the age of 9 months. Furthermore, 11-9 had 8 children and 9 grandchildren, all of whom were healthy.
In the family of G.W. (fig.5 ), 4 generations are illustrated in 3 of which were involved children. Again the disease was observed exclusively in males and, in each instance, transmission was through a female. These women include the sister of involved boys in generation I, her daughters, 11-2, 11-3 and 11-8, and 2 of the daughters of 11-8. There were 9 involved children in this family. Mental retardation, cerebral palsy, and lip biting with destruction of the lower lip were prominent characteristics.
A 'grandmother test' performed on the data from both of these large pedigrees is indicated in table 11. In a trait transmitted as an X-linked recessive, onefourth of the sons of all daughters of carrier females are expected to be affected. In this test of the hypothesis, the observed proportion of affected and unaffected grandsons did not differ significantly from this expectation.
The results of testing with Xga antiserum in kindred JHLBC are given in fig.4 . The other blood typings were consistent with thematernity andpaternitystated. There was no evidence of linkage with the hyperuricemic abnormality of other blood types. The evidence is that throughout most of the kindred the X chromosome carrying the pathologic hyperuricemic gene also Concentrations of uric acid in the serum were determined on 12 of these individuals at various times over the year prior to this study, and values virtually identical to those listed were obtained. Less than complete 24 h samples were obtained on 11-2 and IV-17 and therefore these data are expressed only as mg per mg of creatinine. fig.6 . These data are consistent with the Xlinked dominant hypothesis established by MANN et al. [6] . In matings of Xg (a+) x Xg (a+), there were no negative daughters. With an Xg (a+) male X Xg (a-) female, all male offspring were negative and The screening test for glucose-6-phosphate dehydrogenase was normal in each of the family members for whom Xga testing is listed in fig. 4 . Quantitative assay for the enzyme in some of these was confirmatory, yielding values of 80 to 120 p per 100 ml of erythrocytes, except for 11-3 in whom the value was 294 p per 100 ml of erythrocytes. Testing for color vision was likewise not rewarding in the evaluation of X-chromosoma1 transmission in this kindred.
Concentrations of zaic acid in the plasma and excretion in the urine in family members.
The results of this survey are indicated in table 11. It is clear that the concentration of uric acid in the plasma is not useful in the detection of the abnormal gene. Concentrations in known carriers of generations I11 and IV were not different from those of other members of the family. Only 11-2 had an elevated level, which was 8.48 mg per 100 ml at 75 years of age at the time of this study and 6.2 mg per 100 ml approximately one year previously. The only other individuals with concentrations over 6.0 mg per 100 ml were: 111-3, whose Xga positivity, 4 children and 8 grandchildren, all of whom were uninvolved, suggest that she did not receive the abnormal gene; IV-15, who received her X chromosome of this family from her father; and IV-5, who is the husband of IV-4 and not a product of this family. The distinctly elevated concentration of uric acid in the plasma of 11-3 suggests the possibility that uric acid metabolism may be abnormal in the heterozygote, but elevated concentrations become relatively common with advancing age.
The excretion of uric acid in the urine failed also to distinguish the heterozygous carrier. None of the individuals studied excreted more than 500 mg of uric acid in 24 hours. Identified carriers excreted 241 to 497 mg per 24 hours. These values are certainly comparable to those of their sisters, who may or may not carry the abnormal gene, and to those of the other adult females who almost certainly do not carry the gene, such as 111-6, who is related to the family only through having married 111-5, and her daughter, IV-17. Considered in terms of mg excreted per mg of creatinine, the values in the series of identified carriers were among the highest of the adults studied. The range was from 0.294 to 0.655 with a mean of 0.516 mg per mg of creatinine. On the other hand, there was considerable overlap; the value for IV-4, who could, of course, be a heterozygote, was 0.812, and those of 111-6 and IV-17 were 0.454 and 0.500 mg per mg of creatinine, respectively. These data suggest that there may be some abnormality in uric acid metabolism in the heterozygote, but that it is not regularly possible to detect the presence of the abnormal gene by measuring the excretion of uric acid in the urine.
Analyses of urate excretion were also done on some of the family members at times in which purine intake was not restricted. The mother of the propositus had a 24-hour excretion of 995 mg, while she was eating a regular diet. Her sister, 111-7, excreted 852 mg per 24 hours, and 111-7's daughter, IV-21, 493 mg per 24 hours. Values obtained from the father of the propositus and his twin sons were 0.304, 0.408 and 0.378 mg per mg of creatinine, which did not differ greatly from those obtained with purine restriction. On the other hand, the sister, IV-30, of the propositus excreted 1.21 mg of uric acid per mg of creatinine on a regular diet. These observations indicate that control of the dietary intake of purines is essential for interpretable study of the excretion of uric acid in the urine.
The children in this study excreted relatively large amounts of uric acid per mg of creatinine excreted. Except for IV-34, who was 15 years of age, their excretions ranged from 0.457 to 0.680 with a mean of 0.585 mg per mg of creatinine. This is consistent with previous observations [5] in which uric acid excretion in children was found to be relatively high when expressed as mg of uric acid per kg of body weight.
The adult males were all found to excrete less uric acid than any of the groups of females. The range of data for the males was a relatively narrow one from 0.197 to 0.277 mg per mg creatinine with a mean of 0.237 mg per mg of creatinine. The value for only one of the females, the 63-year-old, 11-9, overlapped this range.
Discussion
The observations recorded provide further confirmation for the concept that the disorder under study is a distinct disease entity. Clinical manifestations are striking. There are variations in severity, even within a single family, but all of the patients have been incapacitated and have been among the severely retarded. Evidence of regression has been observed in a number of these patients, including the propositus, it may be seen as soon as there are teeth. Certain clinical manifestations had not previously been reported. Two patients in this study had infantile colic or later, recurrent abdominal pain. These symptoms are consistent with the passage of large numbers of crystals and occasional calculi [8] along the urinary tract. Similar observations of infantile colic in this disorder have been made by PLATOU [lo] . Destructive activity involving the tongue was seen for the first time in this study and involved a number of members of one kindred. Tophi have previously been rarely observed in this disorder. They were found in 2 patients in this study. There were a number in the patient reported by RILEY [12] and a number have developed in another patient currently under investigation [7] . The development of tophi appears to be a function of the duration of the disease.
The metabolic abnormality in this condition is evident in the amounts of uric acid in the blood and urine. Previous studies [5] have indicated very rapid turnover, as measured using uric acid-2-C14, which exceeded those encountered in gouty adults by approximately 6 tirnes. The most unusual biochemical characteristic of the syndrome is the rate of formation of uric acid from glycine. In these patients, the difference from control approximates 200 times. These observations do not imply a disorder of glycine metabolism, but rather an overproduction of purine that should be demonstrable with any precursor of purine synthesis. The rates of uric acid formation are the highest reported in any condition. The curve for the patient in whom this was documented in this report is virtually identical to those found in the other patients studied with C14-glycine. This similarity is striking in a complicated 7-day metabolic conversion involving a number of enzymatic steps. It suggests the presence of an identical alteration involving a single step responsible for the overall rate of purine biosynthesis.
Genetic data accumulating indicate that this disorder is inherited in an X-linked recessive pattern. The three pedigrees illustrated in this report and kindreds observed by HOEFNAGEL et al. [4] and SHAPIRO et al.
[I41 are all consistent with this hypothesis. The evidence for X-linked inheritance includes the facts that: 1. the disease has been observed only in males; 2. affected males inherit the disease only from their mothers; and 3. the grandmother test does not show a significant deviation from the ratio expected.
The data obtained from Xga typing are consistent with the hypothesis that the abnormal hyperuricemic gene is on the X-chromosome. A single recombination was demonstrated in this study. Other instances of crossing over might not be detectable in this family, in which so many of the carriers were Xga negative. Some Xga typing in a family with this trait has also been carried out by HOEFNAGEI. [4] , who has not reported his data, but stated in discussion that crossover was observed. A much larger body of data will be required to establish the recombination fraction with any security. The testing of additional families would be of considerable interest, both to establish linkage and to contribute to the mapping of the X chromosome. The order of genes on the X chromosome is currently thought to be Xg-G-6-PD-deutan color blindnesshemophilia A. Ultimately, it should be possible to determine the relative position of this abnormal hyperuricemic gene on the chromosome and its relative distances from other genes.
The development of methods for the detection of the heterozygous carrier would be of interest as independent support for the concept of X-chromosomal transmission and from the point of view of genetic counseling. It has been suggested that this may be possible by assessment of the excretion of uric acid in the urine. HOEFNAGEL et al. [4] reported excretions in 3 mothers of involved children of 500, 594 and 825 mg per 24 hours, and SHAPIRO et al. [I41 reported the mother of their proband to excrete 952 mg of uric acid in the urine in 24 hours. Siniilar levels of excretion were observed in the mother of a propositus in this study and in her sister, while they were eating a regular diet. On modest restriction of dietary intake of purines, these women and all of the others in the kindred excreted quantities of uric acid well within the normal range. I t would appear that control of the intake of purines 13 is essential for the elucidation of this problem. We do not doubt the likelihood that there is a detectable abnormality of purine metabolism in the female heterozygous for the gene under consideration. Distinctly elevated 24 hours excretions of uric acid have been documented in this laboratory for some of the same mothers reported by HOEFNAGEL et al. [4] and other identified carriers, even under conditions of rigid control of dietary purine in a Clinical Research Unit. On the other hand, in the course of daily collections under the same conditions on the same mother, values as far apart as 330 and 650 mg per 24 hours have been found. These observations indicate that the regular detection of the heterozygote is more complicated than the simple determination of the amount of uric acid excreted in the urine in 24 hours. Further investigation of this problem is in progress.
Two previously unreported kindreds have been described in which a number of children were affected with a disorder of uric acid metabolism and central nervous system function. The cardinal clinical features include mental retardation, spastic cerebral palsy, choreoathetosis and self-mutilating biting. Metabolic investigation of the propositus of the first family indicated a marked degree of overproduction of uric acid from C14-glycine. Genetic analysis indicated clearly that this is an X-linked recessive disorder of the male.
